Sponsor pipeline

Axsome Therapeutics, Inc. clinical trial pipeline

Get alerts when Axsome Therapeutics, Inc.'s trials change

12 active trials 9 recruiting 10 Phase 3 2 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

Active trials by phase

Phase 3
10
Phase 4
1
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 4
NCT06223880 A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the… Major Depressive Disorder Recruiting 2025-01-23
Phase 3
NCT07717879 Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2) ADHD Recruiting 2026-09-08
NCT07717892 Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3) ADHD Recruiting 2026-09-08
NCT07766655 Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT) Smoking Cessation Recruiting 2026-09-08
NCT07398417 Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research… Fibromyalgia Recruiting 2026-09-04
NCT06413433 Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using… Binge-Eating Disorder Recruiting 2026-07-28
NCT06568367 Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work… Excessive Sleepiness Recruiting 2026-07-24
NCT07484217 Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness… Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms Recruiting 2026-07-24
NCT07773883 An Open-Label Study to Assess the Long-Term Safety of Solriamfetol in Children and… ADHD Enrolling by Invitation 2026-09-08
NCT07637162 Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia Fibromyalgia Enrolling by Invitation 2026-09-04
NCT06878976 A Study to Assess the Long-term Safety and Efficacy of Solriamfetol in Subjects With… Binge-Eating Disorder Enrolling by Invitation 2026-08-11
Not specified
NCT06413420 SUNOSI® (Solriamfetol) Pregnancy Registry Narcolepsy Recruiting 2026-10-05

Disease areas by active trials

ADHD (3) · Depression (2)

Get alerts when Axsome Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free